To these points, autologous tumor cell vaccine with the immunogenic quiescent tumor cells, possibly in combination with IFN-β, may help to present the entire antigen to the immune system and suppress negative immune regulatory mechanisms. The gene discussed is IFNB1; the disease is neoplasm.